Maria Sharapova is keeping busy during her two-year doping suspension from tennis. She has her high-end candy company, so earlier this year she took a two-week course at Harvard Business School. She has interned with an ad agency and with Nike, the shoe company that originally dropped her but then took her back after it was determined that she did not take the banned substance meldonium intentionally.

But Sharapova’s most high-profile internship happened earlier this month, a three-day crash course with the NBA.

“She took part in many of our department meetings to learn about the NBA operations,” Mike Bass, a spokesman for NBA Commissioner Adam Silver, told the New York Post’s Mark Berman. “She’s very smart, incredibly inquisitive about our process and initiatives.”

A final decision on Sharapova’s suspension from the Court of Arbitration for Sport has been deferred until Sept. 19, at the latest. She tested positive for meldonium, which was added to the World Anti-Doping Agency’s banned-substance list only this year, at the Australian Open in January, earning the two-year tennis ban. Sharapova contends that she didn’t know the drug had been banned, but an ITF panel ruled that she bore ”sole responsibility” and ”very significant fault” for the positive test in upholding her suspension.

Coincidentally, Berman reports that the NBA will add meldonium to its banned-substance list in time for the coming season.